Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opioid Growth Factor in Advanced Pancreatic Cancer
NCT00109941Phase 2Completed
- Sponsor
- Penn State Health Milton S. Hershey Medical Center
- Start
- Oct 2003
- Primary completion
- Sep 2007
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of metenkephalin in pancreatic cancer (PC), sponsored by Penn State Health Milton S. Hershey Medical Center. Started Oct 2003; status: completed.
02
Drugs
metenkephalin
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00109941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00109941.